Surgery Doctors in Corning, NY Accepting Medicare

6 Surgery doctors found. Showing 1 - 6

Dr. Amy Jane Kauffman, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3 Guthrie Dr, Corning, NY 14830 Phone: 607-973-8000    Fax: 607-936-6475

Dr. David Lawrence Mccorvey, M.D. Surgery - Plastic and Reconstructive Surgery Medicare: Not Enrolled in Medicare Practice Location: 130 Centerway, Corning, NY 14830 Phone: 607-936-9971    Fax: 607-936-2600

Dr. Rashida S Vassell, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 149 Walnut St, Corning, NY 14830 Phone: 607-654-4440

Latif Aziz Shaikh, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 257 E 1st St, Corning, NY 14830 Phone: 607-936-4679    Fax: 607-936-4670

Dr. John Olmstead, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3 Guthrie Dr, Corning, NY 14830 Phone: 607-973-8000    Fax: 607-936-2600

Dr. James D. Rorabaugh, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 130 Center Way, Corning, NY 14830 Phone: 607-936-9971    Fax: 607-936-6475

News Archive

Cancer patients are four times more likely to commit suicide

People with cancer are more than four times more likely to commit suicide than people without cancer, according to Penn State College of Medicine researchers.

PCR-based reverse genetic system helps analyze SARS-CoV-2 mutations

SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. We know that mutations in the genome of SARS-CoV-2 have occurred and spread, but what effect do those mutations have?

QLT board approves share repurchase program

QLT Inc. announced today that its board of directors has approved the repurchase of up to 3,622,495 common shares of QLT, representing 10% of the public float, over the next 12 months on the NASDAQ Stock Market ("NASDAQ") and the Toronto Stock Exchange ("TSX"), pending required approvals.

Cornea and Laser Eye Institute to study CXL effectiveness in keratoconus patients

The Cornea and Laser Eye Institute, with Principal Investigator, Peter S. Hersh M.D., is conducting a research study to study the safety and effectiveness of corneal collagen crosslinking (CXL) using Riboflavin/Dextran and Hypotonic Riboflavin in patients with progressive keratoconus and corneal ectasia.

Read more Medical News

› Verified 4 days ago